The best practices of medical device product development have a good flow between Design Controls and Risk Management. When you evaluate risks, you will need to establish Risk Controls to mitigate and reduce risks. Let me explain. Risk Controls are used to help identify ways to reduce the risks. Are you starting to see how closely related Risk Management and Design Controls should be? As I go through this guide on medical device risk management, I will often reference the ISO standard the reasons for this are described earlier in this guide.
Medical device Risk Management requires top management involvement. It requires that a company establish a Risk Management Policy. The infographic below aligns directly with the ISO standard on a one to one basis and is a high-level overview of the Risk Management process. Click infographic to enlarge. If you are developing medical devices in this day and age, you absolutely must have an established Risk Management process defined, documented, and implemented.
As you go through this guide, I will share with you all the steps that you need to define and address within your Risk Management procedures.
You need to include end-users, marketing, sales, business development, quality, regulatory, and manufacturing on your product Risk Management team. All of these functional areas provide different perspectives and experiences for the medical devices you are designing, developing, and manufacturing.
There are several key terms pertaining to Risk Management defined in ISO that you definitely need to understand. RISK - combination of the probability of occurrence of harm and the severity of that harm. HARM - physical injury or damage to the health of people, or damage to property or the environment. When this happens, I recommend asking the person to explain what they mean. Getting a grasp on the list of terms above is critical to understanding medical device risk management. Often times, it is assumed that the topic of Risk Management is only the responsibility of the medical device product developers and engineers designing new products.
While it is true that product developers and engineers do play a pivotal role, medical device Risk Management is a much more comprehensive process that should span all functional areas of a medical device.
This means that, in addition to product developers and engineers, other functional areas including business development, marketing, manufacturing, sales, and end-users should be an integral part of your Risk Management process. Executive management is the ultimate authority within the company. Executive management has the responsibility for making sure there are adequate and appropriate resources for conducting risk management activities. This involves determining the risk acceptability criteria.
The criteria should be based on solid, objective evidence, such as industry standards. The Risk Management Plan is dynamic and should be revisited and updated often.
Scope of the Risk Management activities. Define the product included. It is possible to have multiple products described within a single Risk Management Plan.
Define roles and responsibilities. Identify the Risk Management team that will be reviewing and approving risk documentation. Note, that often times this is likely to be defined within your Risk Management Procedure.
Specify methods to verify Risk Control measures are implemented and reduce risks to the pre-established acceptable levels. Define how post-production information will be captured and fed into Risk Management activities for the product. The Risk Management Plan evolves and should be kept current--even after product development is completed. A Risk Management File can be structured and organized by an individual product or for a product family.
A best practice is to keep the contents of the product Risk Management File together in a single location for ease of access and use. This is very difficult to manage and maintain using a paper-based approach. And you can search far and wide for a software solution that is compliant with ISO The starting point for identifying specific risks related to medical device products is Risk Analysis. Many techniques are used throughout the industry, including preliminary hazards analysis, FMEA, and fault tree analysis.
FMEA is a reliability tool that assumes single-fault failures as part of analysis. Risk Management is broader than just failures; risks exist when medical devices are used without failure modes. In my opinion, as you go through Risk Analysis, Risk Evaluation, and Risk Controls, there is a good flow and progression.
You should define an approach that helps you document and capture all of these Risk Management steps which I explain in the Ideal Risk Management Workflow section of this guide. The Risk Analysis must identify the medical device, as well as who was involved, risk analysis scope, and date s. When you start your Risk Analysis, you should work from a documented intended use statement. Yes, this should be the same intended use that you capture as part of Design Controls when defining User Needs and Design Inputs.
Knowing the intended use is important for Risk Management. This statement helps define the scope and will be instrumental as you identify hazards, harms, etc. Once you have defined the intended use, chances are you will be able to also identify cases of foreseeable misuse too.
You should define these and include intentional and unintentional misuse cases. Yes, you should consider off-label uses of the device. The safety characteristics included in your medical device should be identified. Things like special guards or redundant features are good examples. One excellent way to ensure safety characteristics are established and document is to define these as specific Design Inputs in your Design History File.
For your product, you need to identify all the possible hazards. ISO Annex C contains a great list of examples of hazards. To identify hazards, understanding the intended use is important and necessary as well as foreseeable misuse. A good technique for identifying hazards is to go through all the steps required for your product to be used. At each step, identify if there are any potential sources of harm.
But it should also consider end-users, damage to property, and the environment I discuss harm further on in this guide. You may be wondering how you can possibly identify hazards when you do not know exactly what your medical device is going to be. I understand this might be challenging early on during product development. And I encourage you to attempt to identify hazards as early in the medical device product development process as possible.
Doing so ensures that your Design Controls and Risk Management activities are in sync. And there is only one software platform designed specifically to integrate Design Controls and Risk Management. Yep, you guessed it: Greenlight Guru. For a hazardous situation to occur, there has to be a foreseeable sequence of events that lead to this.
Once again, understanding the intended use and the steps involved in using your medical device should help guide you through this process. The foreseeable sequence of events that someone will go through in using your product, which can result in a hazardous situation, should also be identified.
As you can see from the provided example, in order for the Hazardous Situation to occur, there are a series of things that must happen first Foreseeable Sequence of Events. Hazards and Hazardous Situations are much broader than just failure modes.
I should also remind you of the definition of harm. Harm is physical injury or damage to the health of people, or damage to property or the environment. A common technique that is used is defining descriptions for various levels for both severity and probability of occurrence. They are organized into four areas: 1 health care technologies, including medical devices and health information technologies involved in health care in the home; 2.
Although many issues related to home health care could not be addressed, applications of human factors principles, knowledge, and research methods in these areas could make home health care safer and more effective and also contribute to reducing costs. The committee chose not to prioritize the recommendations, as they focus on various aspects of health care in the home and are of comparable importance to the different constituencies affected.
Health care technologies include medical devices that are used in the home as well as information technologies related to home-based health care. The four recommendations in this area concern 1 regulating technologies for health care consumers, 2 developing guidance on the structure and usability of health information technologies, 3 developing guidance and standards for medical device labeling, and 4 improving adverse event reporting systems for medical devices.
The adoption of these recommendations would improve the usability and effectiveness of technology systems and devices, support users in understanding and learning to use them, and improve feedback to government and industry that could be used to further improve technology for home care.
Ensuring the safety of emerging technologies is a challenge, in part because it is not always clear which federal agency has regulatory authority and what regulations must be met.
Currently, the U. However, the dividing line between medical devices and health information technology is blurring, and many new systems and applications are being developed that are a combination of the two, although regulatory oversight has remained divided. Because regulatory responsibility for them is unclear, these products may fall into the gap. The committee did not find a preponderance of evidence that knowledge is lacking for the design of safe and effective devices and technologies for use in the home.
Rather than discovering an inadequate evidence base, we were troubled by the insufficient attention directed at the development of devices that account, necessarily and properly, for users who are inadequately trained or not trained at all.
Yet these new users often must. The increased prominence of the use of technology in the health care arena poses predictable challenges for many lay users, especially people with low health literacy, cognitive impairment, or limited technology experience.
With the spectrum of caregivers ranging from individuals caring for themselves or other family members to highly experienced professional caregivers, computer-based care management systems could offer varying levels of guidance, reminding, and alerting, depending on the sophistication of the operator and the criticality of the message.
However, if these technologies or applications are difficult to understand or use, they may be ignored or misused, with potentially deleterious effects on care recipient health and safety. Applying existing accessibility and usability guidelines and employing user-centered design and validation methods in the development of health technology products designed for use in the home would help ensure that they are safe and effective for their targeted user populations.
In this effort, it is important to recognize how the line between medical devices and health information technologies has become blurred while regulatory oversight has remained distinct, and it is not always clear into which domain a product falls. Recommendation 1.
The U. Food and Drug Administration and the Office of the National Coordinator for Health Information Technology should collaborate to regulate, certify, and monitor health care applications and systems that integrate medical devices and health information technologies.
As part of the certification process, the agencies should require evidence that manufacturers have followed existing accessibility and usability guidelines and have applied user-centered design and validation methods during development of the product. Developers of information technologies related to home-based health care, as yet, have inadequate or incomplete guidance regarding product content, structure, accessibility, and usability to inform innovation or evolution of personal health records or of care recipient access to information in electronic health records.
The ONC, in the initial announcement of its health information technology certification program, stated that requirements would be forthcom-. Despite the importance of these requirements, there is still no guidance on the content of information that should be provided to patients or minimum standards for accessibility, functionality, and usability of that information in electronic or nonelectronic formats.
Consequently, some portals have been constructed based on the continuity of care record. However, recent research has shown that records and portals based on this model are neither understandable nor interpretable by laypersons, even by those with a college education. The lack of guidance in this area makes it difficult for developers of personal health records and patient portals to design systems that fully address the needs of consumers.
Recommendation 2. The Office of the National Coordinator for Health Information Technology, in collaboration with the National Institute of Standards and Technology and the Agency for Healthcare Research and Quality, should establish design guidelines and standards, based on existing accessibility and usability guidelines, for content, accessibility, functionality, and usability of consumer health information technologies related to home-based health care.
The committee found a serious lack of adequate standards and guidance for the labeling of medical devices. Furthermore, we found that the approval processes of the FDA for changing these materials are burdensome and inflexible. Just as many medical devices currently in use by laypersons in the home were originally designed and approved for use only by professionals in formal health care facilities, the instructions for use and training materials were not designed for lay users, either.
The committee recognizes that lack of instructional materials for lay users adds to the level of risk involved when devices are used by populations for whom they were not intended. Changing the instructions for use which were approved with the device requires manufacturers to submit the device along with revised instructions to the FDA for another k premarket notification review.
Since manufacturers can find these reviews complicated, time-consuming, and expensive, this requirement serves as a disincentive to appropriate revisions of instructional or training materials. Even the recently released human factors standard on medical device design Association for the Advancement of Medical Instrumentation, , while reasonably comprehensive, does not cover the topic of training or training materials. Both FDA guidance and existing standards that do specifically address the design of labeling and ensuing instructions for use fail to account for up-to-date findings from research on instructional systems design.
In addition, despite recognition that requirements for user training, training materials, and instructions for use are different for lay and professional users of medical equipment, these differences are not reflected in current standards. Recommendation 3. Food and Drug Administration FDA should promote development by standards development organizations, such as the International Electrotechnical Commission, the International Organization for Standardization, the American National Standards Institute, and the Association for the Advancement of Medical Instrumentation of new standards based on the most recent human factors research for the labeling of and ensuing instructional materials for medical devices designed for home use by lay users.
The FDA should also tailor and streamline its approval processes to facilitate and encourage regular improvements of these materials by manufacturers. In order to promote safe use of medical devices in the home and rectify design problems that put care recipients at risk, it is necessary that the FDA conduct more effective postmarket surveillance of medical devices to complement its premarket approval process.
The most important elements of their primarily passive surveillance system are the current adverse event reporting mechanisms, including Maude and MedSun. Entry of incident data by health care providers and consumers is not straightforward, and the system does not elicit data that could be useful to designers as they develop updated versions of products or new ones that are similar to existing devices.
The reporting systems and their importance need to be widely promoted to a broad range of users, especially lay users. Recommendation 4. Food and Drug Administration should improve its adverse event reporting systems to be easier to use, to collect data that are more useful for identifying the root causes of events.
Health care is provided in the home by formal caregivers health care professionals , informal caregivers family and friends , and individuals who self-administer care; each type of caregiver faces unique issues. Properly preparing individuals to provide care at home depends on targeting efforts appropriately to the background, experience, and knowledge of the caregivers.
J Neurosurg. Neurol Med Chir Tokyo. Life Basel. Expert Rev Neurother. Epub May 6. Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia. Nat Commun. Comparison of efficacy of deep brain stimulation and focused ultrasound in parkinsonian tremor: a systematic review and network meta-analysis.
J Neurol Neurosurg Psychiatry. N Engl J Med. Perlmutter J, Ushe M. JNS 27 Nov MRI-based thermal dosimetry based on single-slice imaging during focused ultrasound thalamotomy. Phys Med Biol. Curr Gene Ther. What is AMDM? Asked By Wiki User. Use an area model to determine the theoretical probability of a customer taking home a pumpkin. Alle Nicht Jeder. Unit 3. MMSI: Anytime, anywhere, across your devices. For each problem you had to find the next three terms, identify the type of sequence, write the recursive and explicit definitions, and find the 12th term.
Click the following link: Texas Reality Check Select option 1. Unit 6. Although it may feel like you're playing a game, your brain is still making more connections with the information to help you out. What does AMDM stand for?
0コメント